High levels of cerebrospinal fluid (CSF) total tau levels and low levels of CSF amyloid-β1–42 were reported to be predictors of rapid cognitive decline in AD (Koch et al., 2013). The gene discussed is MAPT; the disease is Alzheimer disease.